Healing Minds, Restoring Lives
Providing ketamine therapy for depression, anxiety, PTSD, OCD, and certain types of chronic nerve pain.
☎(925) 489-2984 ✉ info@vividlifeclinic.com
Providing ketamine therapy for depression, anxiety, PTSD, OCD, and certain types of chronic nerve pain.
SPRAVATO® is now approved as the first and only treatment used as monotherapy for adults living with treatment-resistant depression.
SPRAVATO® is the only FDA-approved treatment used as monotherapy or in conjunction with an oral antidepressant for adults with treatment-resistant depression (MDD* with inadequate response to at least 2 oral antidepressants of adequate dose and duration)
SPRAVATO® is a unique treatment approach that delivers:
*Major Depressive Disorder
Featured on CBS Bay Area - American Health Front
Dr. Anthony Aguirre discusses ketamine therapy, with patients sharing their personal treatment experiences.
For many people , traditional treatments don't provide meaningful relief. Ketamine offers a different approach. Backed by decades of medical use and modern research, ketamine therapy has been shown to help reduce symptoms of depression, anxiety, PTSD and certain types of chronic pain.
Spravato® (Esketamine) is a nasal spray that is chemically similar to ketamine which is administered in the office. It is FDA-approved and is covered by insurance.
Fast-Acting
While most traditional antidepressants can take weeks or months to reach full effect, ketamine often begins working more quickly. Many patients report noticeable improvement within hours to days, with benefits building over the first several treatments.
Effective
Ketamine has been shown to significantly improve symptoms for many people with depression and other mental health conditions, including individuals who have not responded to traditional treatments. While responses vary, clinical studies and real world experience demonstrate that a substantial proportion of patients experience meaningful benefit.
Safe
Ketamine has a well-established safety profile when administered by trained medical professionals. The doses used for mental health and chronic nerve pain conditions are significantly lower than those used in anesthesia, and treatments are provided in a controlled medical setting with appropriate monitoring.
Major Depressive Disorder (MDD), commonly referred to as depression, is a mental health condition characterized by persistent feelings of sadness, hopelessness, worthlessness, and a loss of interest or pleasure in activities that were once enjoyable. It can interfere with your ability to function normally. It affects how you feel, think, and handle daily activities which can be extremely debilitating.
Treatment-resistant depression (TRD) is a term used to describe depression that persists despite adequate trials of two or more antidepressant medications at an adequate dose and duration, as well as psychotherapy. It is estimated that around one-third of individuals with depression may experience treatment resistance at some point during their illness. Studies have shown that approximately 75% of people living with TRD respond to ketamine treatment.
Anxiety disorders are among the most common mental illnesses in the United States. Nearly 1 out of every 5 American adults suffer from some form of chronic anxiety. Anxiety disorders are a group of mental health conditions characterized by excessive and persistent feelings of fear, worry, or anxiety. These symptoms are difficult to control and significantly interfere with daily functioning.
Post-Traumatic Stress Disorder (PTSD) is a mental health condition that can develop in people who have experienced or witnessed a traumatic or life-threatening event. There are no particular types of events that automatically cause PTSD. However, there are certain situations that are more likely to lead to PTSD due to their strong emotional component such as physical and sexual assault, motor vehicle accidents, war, and life threatening situations.
Recent studies have demonstrated that ketamine can effectively treat PTSD symptoms up to 70% of people. In addition, the results frequently begin to take effect within hours or days instead of weeks or months for the usual PTSD medications.
Obsessive-compulsive disorder (OCD) is a mental health disorder that is characterized by a pattern of unwanted thoughts, fears, urges (obsessions) that lead to repetitive behaviors (compulsions). People with OCD may experience persistent, intrusive thoughts and engage in ritualistic behaviors to manage the anxiety these thoughts produce.
OCD interfere with daily life by absorbing the patient’s time and keeping them from engaging in other activities that they truly enjoy doing. It can significantly impair someone’s ability to work, attend to their family, and keep meaningful relationships. Most people with OCD realize that these obsessions are irrational but they are unable to stop themselves from having it. Researchers have shown that approximately 50% of people suffering from near constant (more than 8 hours a day) OCD symptoms obtain significant relief with ketamine therapy.
Complex regional pain syndrome (CRPS) is an uncommon condition that causes pain, usually in your upper and lower extremities. CRPS typically develops after an injury, surgery, stroke or heart attack. The pain is out of proportion to the severity of the initial injury.
It is believed that CRPS occurs as a result of dysfunction in your central or peripheral nervous systems. Your central nervous system consists of your brain and spinal cord whereas your peripheral nervous system sends information from your brain and spinal cord to your arms, legs, fingers and toes. The abnormal functioning results in an overreaction to pain signals that your nervous system can’t shut off. Symptoms of CRPS include burning or throbbing pain, sensitivity to touch or cold, changes in skin color (from white and blotchy to red or blue. Ketamine can be considered when more traditional forms of treatment have been tried and failed to produce relief from symptoms.